Loss of vision has a profound impact on a person's life: financially, economically and socially. The incidence of eye disease is increasing with a global ageing population.
IBM Research Australia is developing Artificial Intelligence (AI) solutions to identify early signs of common eye diseases like Glaucoma and Diabetic Retinopathy. In this talk, Dr Natalie Gunn and Dr Stefan Maetschke will shed light on the current capabilities of our technologies, and share their perspective on how these technologies can help make a difference to the prevention and identification of eye disease, and keep us all active for longer. Find out more